First Trust Exchange-Traded Fund VI. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| ELI LILLY & COMPANYLLY | 7.77% | $2.82M | 2,347 |
| ABBVIE INCABBV | 7.39% | $2.68M | 10,640 |
| MERCK & COMPANY INCMRK | 7.07% | $2.56M | 19,942 |
| JOHNSON & JOHNSONJNJ | 6.96% | $2.52M | 9,939 |
| BRISTOL-MYERS SQUIBB COMPANYBMY | 6.29% | $2.28M | 39,590 |
| BIOGEN INCBIIB | 3.84% | $1.39M | 6,436 |
| VIATRIS INCVTRS | 3.62% | $1.31M | 82,694 |
| CARDINAL HEALTH INCCAH | 3.53% | $1.28M | 5,386 |
| VERTEX PHARMACEUTICALS INCVRTX | 3.41% | $1.23M | 2,485 |
| AMGEN INCAMGN | 3.18% | $1.15M | 3,181 |
| PFIZER INCPFE | 2.97% | $1.08M | 44,652 |
| GILEAD SCIENCES INCGILD | 2.89% | $1.05M | 8,289 |
| UNITED THERAPEUTICS CORPUTHR | 2.72% | $987.21K | 1,822 |
| REGENERON PHARMACEUTICALS INCREGN | 2.72% | $984.57K | 1,579 |
| JAZZ PHARMACEUTICALS PLC | 2.49% | $901.47K | 3,741 |
| INCYTE CORPINCY | 2.39% | $866.98K | 7,648 |
| ILLUMINA INCILMN | 1.98% | $718.79K | 4,088 |
| ZOETIS INCZTS | 1.87% | $676.71K | 9,417 |
| EXELIXIS INCEXEL | 1.72% | $625.06K | 11,488 |
| CHARLES RIVER LABORATORIES INTERNATIONAL INCCRL | 1.49% | $539.08K | 2,377 |
| MEDPACE HOLDINGS INCMEDP | 1.41% | $511.58K | 966 |
| PTC THERAPEUTICS INCPTCT | 1.37% | $496.84K | 6,091 |
| NEUROCRINE BIOSCIENCES INCNBIX | 1.37% | $495.32K | 2,939 |
| ALKERMES PLC | 1.35% | $490.73K | 9,366 |
| HALOZYME THERAPEUTICS INCHALO | 1.21% | $437.76K | 5,593 |
| BIOMARIN PHARMACEUTICAL INCBMRN | 1.11% | $404.03K | 7,061 |
| TWIST BIOSCIENCE CORPTWST | 1.03% | $372.32K | 3,619 |
| SPYRE THERAPEUTICS INCSYRE | 0.97% | $350.50K | 3,948 |
| TRAVERE THERAPEUTICS INCTVTX | 0.89% | $323.82K | 5,700 |
| TG THERAPEUTICS INCTGTX | 0.86% | $310.03K | 5,643 |
| ELANCO ANIMAL HEALTH INCELAN | 0.83% | $300.49K | 12,210 |
| 10X GENOMICS INCTXG | 0.78% | $282.45K | 7,367 |
| GUARDANT HEALTH INCGH | 0.75% | $271.25K | 1,808 |
| LIGAND PHARMACEUTICALS INCLGND | 0.75% | $270.57K | 856 |
| ARCUS BIOSCIENCES INCRCUS | 0.71% | $257.00K | 8,336 |
| AMNEAL PHARMACEUTICALS INCAMRX | 0.69% | $251.19K | 14,511 |
| ARROWHEAD PHARMACEUTICALS INCARWR | 0.66% | $237.85K | 2,918 |
| CATALYST PHARMACEUTICALS INC | 0.64% | $231.23K | 7,357 |
| KRYSTAL BIOTECH INCKRYS | 0.63% | $228.95K | 616 |
| PROTAGONIST THERAPEUTICS INCPTGX | 0.62% | $226.04K | 1,844 |
| MODERNA INCMRNA | 0.61% | $222.00K | 3,170 |
| MIRUM PHARMACEUTICALS INCMIRM | 0.59% | $215.41K | 1,840 |
| KYMERA THERAPEUTICS INCKYMR | 0.59% | $213.17K | 1,859 |
| ROIVANT SCIENCES LTD | 0.57% | $207.67K | 5,868 |
| ACADIA PHARMACEUTICALS INCACAD | 0.48% | $174.92K | 6,914 |
| IONIS PHARMACEUTICALS INCIONS | 0.46% | $165.95K | 2,093 |
| ARCUTIS BIOTHERAPEUTICS INCARQT | 0.46% | $165.08K | 6,296 |
| ALNYLAM PHARMACEUTICALS INCALNY | 0.42% | $153.53K | 510 |
| SUPERNUS PHARMACEUTICALS INCSUPN | 0.40% | $144.32K | 3,103 |
| TARSUS PHARMACEUTICALS INCTARS | 0.39% | $141.55K | 2,249 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.